3
Announcements
Trials
Browse
Landscape
Status
No longer available
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
3
Expanded_access
2
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Urogenital Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Interventions
3-Iodobenzylguanidine
2
Cyclophosphamide
2
Gemcitabine
2
Insulin Infusion Systems
2
Powders
2
Suspensions
2
balstilimab
2
leronlimab
2
ruxolitinib
2
talquetamab
2
Abiraterone Acetate
1
Alpelisib
1
Androgen Antagonists
1
Asparaginase
1
Bone Marrow Transplantation
1
Capecitabine
1
Docetaxel
1
Eflornithine
1
HMPL-013
1
Hydrocortisone
1
Immunotherapy, Adoptive
1
LY3023414
1
Magnetic Resonance Spectroscopy
1
Methionine
1
Nivolumab
1
Paclitaxel
1
Peripheral Blood Stem Cell Transplantation
1
Prednisolone
1
Prednisone
1
Proton Pump Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Expanded_access
×
Suspensions
×
1 year
×
Clear all
NCT03756311
2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
NCT04060628
2026-01-23
Expanded Access to NanoDoce
NanOlogy, LLC
No longer available